Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review
P Anversa,
R Ricci,
and
G Olivetti
The quantitative structural properties of the ventricular myocardium during postnatal physiologic growth are compared with those accompanying an increased load in the adult rat heart to determine whether induced cardiac hypertrophy is a pathologic condition or simply a form of well compensated accelerated growth. The expansion of the ventricular myocardium during maturation shows a remarkable degree of well balanced compensatory response, because the capillary microvasculature, parenchymal cells and subcellular components of myocytes all grow in proportion to the increase in cardiac mass. In contrast, the increases in myocyte diameter and length caused by pressure hypertrophy, volume hypertrophy and infarction-induced hypertrophy are consistent with concentric, eccentric and a combination of concentric and eccentric hypertrophic growth of the whole ventricle, respectively. These cellular shape changes may represent a compensatory response of the myocardium at the cellular level of organization that tends to minimize the effects of an increased pressure or volume load, or both, on the heart. Cardiac hypertrophy, however, may also show alterations affecting capillary luminal volume and surface and the mitochondrial to myofibril volume ratio, which indicate an inadequate growth adaptation of the component structures responsible for tissue oxygenation and energy production. Thus, hypertrophy of the adult heart differs from that during physiologic growth, and the hypertrophied myocardium may exhibit structural abnormalities that can be expected to increase its vulnerability to ischemia.
This article has been cited by other articles:

|
 |

|
 |
 
S. G. Haworth
The cell and molecular biology of right ventricular dysfunction in pulmonary hypertension
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H10 - H16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Westenbrink, E. Lipsic, P. van der Meer, P. van der Harst, H. Oeseburg, G. J. Du Marchie Sarvaas, J. Koster, A. A. Voors, D. J. van Veldhuisen, W. H. van Gilst, et al.
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization
Eur. Heart J.,
August 2, 2007;
28(16):
2018 - 2027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C.D. Abduch, R. S. Assad, M. Q. Rodriguez, A. S. Valente, J. L. Andrade, L. M.M. Demarchi, M. B. Marcial, and V. D. Aiello
Reversible pulmonary trunk banding III: Assessment of myocardial adaptive mechanisms--contribution of cell proliferation
J. Thorac. Cardiovasc. Surg.,
June 1, 2007;
133(6):
1510 - 1516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Li, H. Yin, Y.-Y. Yao, B. Shen, M. Bader, L. Chao, and J. Chao
Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3{beta} activation
Cardiovasc Res,
January 1, 2007;
73(1):
130 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Leri, J. Kajstura, and P. Anversa
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
Physiol Rev,
October 1, 2005;
85(4):
1373 - 1416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Casey, P. G. Arthur, and M. A. Bogoyevitch
Proteomic Analysis Reveals Different Protein Changes during Endothelin-1- or Leukemic Inhibitory Factor-induced Hypertrophy of Cardiomyocytes in Vitro
Mol. Cell. Proteomics,
May 1, 2005;
4(5):
651 - 661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Dahlstrom
Frequent non-cardiac comorbidities in patients with chronic heart failure
Eur J Heart Fail,
March 16, 2005;
7(3):
309 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Holmes
Candidate mechanical stimuli for hypertrophy during volume overload
J Appl Physiol,
October 1, 2004;
97(4):
1453 - 1460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Jayasankar, Y. J. Woo, L. T. Bish, T. J. Pirolli, M. F. Berry, J. Burdick, R. C. Bhalla, R. V. Sharma, T. J. Gardner, and H. L. Sweeney
Inhibition of Matrix Metalloproteinase Activity by TIMP-1 Gene Transfer Effectively Treats Ischemic Cardiomyopathy
Circulation,
September 14, 2004;
110(11_suppl_1):
II-180 - II-186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. A. McCrossan, R. Billeter, and E. White
Transmural changes in size, contractile and electrical properties of SHR left ventricular myocytes during compensated hypertrophy
Cardiovasc Res,
August 1, 2004;
63(2):
283 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Corno, G. Milano, S. Morel, P. Tozzi, C. Y. Genton, M. Samaja, and L. K. von Segesser
Hypoxia: Unique myocardial morphology?
J. Thorac. Cardiovasc. Surg.,
May 1, 2004;
127(5):
1301 - 1308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Miller, C. L. Wong, and D. Sedmera
Pressure overload alters stress-strain properties of the developing chick heart
Am J Physiol Heart Circ Physiol,
November 1, 2003;
285(5):
H1849 - H1856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gonzalez, M. A Fortuno, R. Querejeta, S. Ravassa, B. Lopez, N. Lopez, and J. Diez
Cardiomyocyte apoptosis in hypertensive cardiomyopathy
Cardiovasc Res,
September 1, 2003;
59(3):
549 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Diffee and D. F. Nagle
Regional differences in effects of exercise training on contractile and biochemical properties of rat cardiac myocytes
J Appl Physiol,
July 1, 2003;
95(1):
35 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chatterjee, L. T. Bish, V. Jayasankar, A. S. Stewart, Y. J. Woo, M. T. Crow, T. J. Gardner, and H. L. Sweeney
Blocking the development of postischemic cardiomyopathy with viral gene transfer of the apoptosis repressor with caspase recruitment domain
J. Thorac. Cardiovasc. Surg.,
June 1, 2003;
125(6):
1461 - 1469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Fortuno, A. Gonzalez, S. Ravassa, B. Lopez, and J. Diez
Clinical implications of apoptosis in hypertensive heart disease
Am J Physiol Heart Circ Physiol,
May 1, 2003;
284(5):
H1495 - H1506.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A J Natali, L A Wilson, M Peckham, D L Turner, S M Harrison, and E White
Different regional effects of voluntary exercise on the mechanical and electrical properties of rat ventricular myocytes
J. Physiol.,
June 15, 2002;
541(3):
863 - 875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yang, P. J I Salas, T. V Pham, B. J Wasserlauf, M. J D Smets, R. J Myerburg, H. Gelband, B. F Hoffman, and A. L Bassett
Cytoskeletal actin microfilaments and the transient outward potassium current in hypertrophied rat ventriculocytes
J. Physiol.,
June 1, 2002;
541(2):
411 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A Babiker, L. J De Windt, M. van Eickels, C. Grohe, R. Meyer, and P. A Doevendans
Estrogenic hormone action in the heart: regulatory network and function
Cardiovasc Res,
February 15, 2002;
53(3):
709 - 719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.M. DALLABRIDA and M.A. RUPNICK
Vascular Endothelium in Tissue Remodeling: Implications for Heart Failure
Cold Spring Harb Symp Quant Biol,
January 1, 2002;
67(0):
417 - 428.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Calderone, R. J. L. Murphy, J. Lavoie, F. Colombo, and L. Beliveau
TGF-{beta}1 and prepro-ANP mRNAs are differentially regulated in exercise-induced cardiac hypertrophy
J Appl Physiol,
August 1, 2001;
91(2):
771 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Natali, D. Turner, S. Harrison, and E White
Regional effects of voluntary exercise on cell size and contraction-frequency responses in rat cardiac myocytes
J. Exp. Biol.,
January 3, 2001;
204(6):
1191 - 1199.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Masuyama, K. Yamamoto, Y. Sakata, R. Doi, N. Nishikawa, H. Kondo, K. Ono, T. Kuzuya, M. Sugawara, and M. Hori
Evolving changes in Doppler mitral flow velocity pattern in rats with hypertensive hypertrophy
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2333 - 2338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.Y.H Lip, D.C Felmeden, F.L Li-Saw-Hee, and D.G Beevers
Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
Eur. Heart J.,
October 2, 2000;
21(20):
1653 - 1665.
[PDF]
|
 |
|

|
 |

|
 |
 
K. AMANN, K. MÜNTER, S. WESSELS, J. WAGNER, V. BALAJEW, S. HERGENRÖDER, G. MALL, and E. RITZ
Endothelin A Receptor Blockade Prevents Capillary/Myocyte Mismatch in the Heart of Uremic Animals
J. Am. Soc. Nephrol.,
September 1, 2000;
11(9):
1702 - 1711.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. S. Assad, M. Cardarelli, M. C. Abduch, V. D. Aiello, M. Maizato, M. Barbero-Marcial, and A. Jatene
Reversible pulmonary trunk banding with a balloon catheterAssessment of rapid pulmonary ventricular hypertrophy
J. Thorac. Cardiovasc. Surg.,
July 1, 2000;
120(1):
66 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Olivetti, E. Cigola, R. Maestri, C. Lagrasta, D. Corradi, and F. Quaini
Recent advances in cardiac hypertrophy
Cardiovasc Res,
January 1, 2000;
45(1):
68 - 75.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Skolnick, S. E. Litwin, W. H. Barry, and K. W. Spitzer
Effect of ANG II on pHi, [Ca2+]i, and contraction in rabbit ventricular myocytes from infarcted hearts
Am J Physiol Heart Circ Physiol,
November 1, 1998;
275(5):
H1788 - H1797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Jorgensen, O. Demirkaya, and E. L. Ritman
Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT
Am J Physiol Heart Circ Physiol,
September 1, 1998;
275(3):
H1103 - H1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Anversa and J. Kajstura
Ventricular Myocytes Are Not Terminally Differentiated in the Adult Mammalian Heart
Circ. Res.,
July 13, 1998;
83(1):
1 - 14.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nanna, L. E. Shapiro, R. Sievert, L. Ong, E. L. Ocampo, R. A. Chance, M. Lee, M. Nanna, K. Ferrick, and M. I. Surks
Minimal Cardiac Effects in Asymptomatic Athyreotic Patients Chronically Treated with Thyrotropin-suppressive Doses of L-Thyroxine--Authors' Response
J. Clin. Endocrinol. Metab.,
July 1, 1998;
83(7):
2607a - 2608.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Kozakova, C. Palombo, L. Pratali, G. Pittella, F. Galetta, and A. L'Abbate
Mechanisms of Coronary Flow Reserve Impairment in Human Hypertension: An Integrated Approach by Transthoracic and Transesophageal Echocardiography
Hypertension,
February 1, 1997;
29(2):
551 - 559.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. C. Wollert, T. Taga, M. Saito, M. Narazaki, T. Kishimoto, C. C. Glembotski, A. B. Vernallis, J. K. Heath, D. Pennica, W. I. Wood, et al.
Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy
J. Biol. Chem.,
April 19, 1996;
271(16):
9535 - 9545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yamamoto, T. N. James, K.-i. Sawada, M. Okabe, and K. Kawamura
Generation of New Intercellular Junctions Between Cardiocytes : A Possible Mechanism Compensating for Mechanical Overload in the Hypertrophied Human Adult Myocardium
Circ. Res.,
March 1, 1996;
78(3):
362 - 370.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Calderone, N. Takahashi, N. J. Izzo Jr, C. M. Thaik, and W. S. Colucci
Pressure- and Volume-Induced Left Ventricular Hypertrophies Are Associated With Distinct Myocyte Phenotypes and Differential Induction of Peptide Growth Factor mRNAs
Circulation,
November 1, 1995;
92(9):
2385 - 2390.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Nicoletti, D. Heudes, N. Hinglais, M.-D. Appay, M. Philippe, C. Sassy-Prigent, J. Bariety, and J.-B. Michel
Left Ventricular Fibrosis in Renovascular Hypertensive Rats : Effect of Losartan and Spironolactone
Hypertension,
July 1, 1995;
26(1):
101 - 111.
[Abstract]
[Full Text]
|
 |
|
|